TargetMol

Ozagrel hydrochloride

Product Code:
 
TAR-T6625
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T6625-1mL1 mL * 10 mM (in DMSO)£96.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6625-10mg10mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6625-25mg25mg£133.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6625-50mg50mg£166.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6625-100mg100mg£216.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6625-200mg200mg£287.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Ozagrel HCl is a selective thromboxane A(2) synthetase inhibitor used for the improvement of postoperative cerebrovascular contraction and accompanying cerebral ischaemia.
CAS:
78712-43-3
Formula:
C13H13ClN2O2
Molecular Weight:
264.71
Pathway:
Proteases/Proteasome; GPCR/G Protein; Immunology/Inflammation
Purity:
0.9957
SMILES:
Cl.OC(=O)C=Cc1ccc(Cn2ccnc2)cc1
Target:
Thrombin; Prostaglandin Receptor

References

Naito J, et al. Eur J Pharmacol. 1983, 91(1), 41-48. Ishitsuka Y, et al. J Pharm Pharmacol, 2004, 56(4), 513-520. Ichikawa K, et al. Pharmacology, 1999, 59(5), 257-265. Ishitsuka Y, et al. J Pharmacol Sci, 2009, 111(2), 211-215. Imamura T, et al. Arzneimittelforschung, 2003, 53(10), 688-694.